# Boston Scientific Corporation (NYSE: BSX), Minnetonka, MN – FDA Inspections

Source: https://www.keypedia.com/companies/boston-scientific-corporation/e946cdb3-4277-49e2-91b8-a3e3437a0104

> Inspection records and compliance data for Boston Scientific Corporation in Minnetonka, Minnesota. 8 FDA inspections on record (1 OAI), last inspected December 11, 2017. Publicly traded as NYSE: BSX.

---

## Details

- Name: Boston Scientific Corporation
- FEI Number: 1000116179
- Address Line 1: 10700 Bren Rd W
- City: Minnetonka
- State: Minnesota
- Zip Code: 55343
- Country Name: United States
- Address: 10700 Bren Rd W, Minnetonka, Minnesota 55343, United States
- Country: United States

## Stock

- Stock ticker: BSX
- Exchange: NYSE
- Share price: $44.61
- Market cap: $64.7B
- Price as of: November 6, 2026

## Related Documents

- FDA Inspection 1036678 - Boston Scientific Corporation - 2017-12-11 — classification: No Action Indicated (NAI), source: FDA, date: December 11, 2017
- FDA Inspection 1018598 - Boston Scientific Corporation - 2017-06-27 — classification: No Action Indicated (NAI), source: FDA, date: June 27, 2017
- [FDA Inspection 958603 - Boston Scientific Corporation - 2016-01-29](https://www.keypedia.com/records/fda_inspections/boston-scientific-corporation/2b4b8339-b086-4055-86a0-636f3e6a3a52) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 29, 2016
- [FDA Inspection 868462 - Boston Scientific Corporation - 2014-02-24](https://www.keypedia.com/records/fda_inspections/boston-scientific-corporation/718541cc-3044-4236-8a4f-16ab15fcfc50) — classification: Official Action Indicated (OAI), source: FDA, date: February 24, 2014
- FDA Inspection 828801 - Boston Scientific Corporation - 2013-04-25 — classification: No Action Indicated (NAI), source: FDA, date: April 25, 2013
- FDA Inspection 818398 - Boston Scientific Corporation - 2013-02-15 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 15, 2013
- FDA Inspection 818398 - Boston Scientific Corporation - 2013-02-15 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 15, 2013
- [FDA Inspection 733567 - Boston Scientific Corporation - 2011-07-13](https://www.keypedia.com/records/fda_inspections/boston-scientific-corporation/595e1509-7622-4620-aed3-9170f3418be6) — classification: No Action Indicated (NAI), source: FDA, date: July 13, 2011
- FDA Inspection 733567 - Boston Scientific Corporation - 2011-07-13 — classification: No Action Indicated (NAI), source: FDA, date: July 13, 2011
- FDA Inspection 564982 - Boston Scientific Corporation - 2009-01-28 — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 28, 2009

## Related Companies

- [Ortho Development Corporation](https://www.keypedia.com/companies/ortho-development-corporation/806e6b13-b860-41d7-a853-e90a844fe86d)
- [Fresenius Kabi Warrendale](https://www.keypedia.com/companies/fresenius-kabi-warrendale/b2524c54-2bb4-4977-9ea7-d82266551b76)
- [OraSure Technologies, Inc.](https://www.keypedia.com/companies/orasure-technologies-inc/720b9d90-ff16-477c-a8a1-57eaac2aac4b)
- [Abbott Laboratories](https://www.keypedia.com/companies/abbott-laboratories/03bab72e-0014-4d1d-afdf-7177588b7f36)
- [KMC Systems, Inc.](https://www.keypedia.com/companies/kmc-systems-inc/0e8d51c9-d4ae-42c0-b29b-88d740c57788)
- [Celera Corporation](https://www.keypedia.com/companies/celera-corporation/03a7f1b1-793b-47a3-9a48-d7a5107661e3)
- [Beth Israel Deaconess Hospital Plymouth](https://www.keypedia.com/companies/beth-israel-deaconess-hospital-plymouth/2e138e0e-4868-417d-a5ab-9ffc76aa5021)
- [Univ. Of Miami Hosp & Clinics](https://www.keypedia.com/companies/univ-of-miami-hosp-clinics/8d070fc2-246e-4b3b-b367-a24adf589073)
- [Contra Costa Regional Medical Center](https://www.keypedia.com/companies/contra-costa-regional-medical-center/f1b71a5c-48d9-4ee5-9a22-2a524e652b8f)
- [Abbott Molecular, Inc.](https://www.keypedia.com/companies/abbott-molecular-inc/0efa8842-5f5e-4dd9-a381-edf99492a332)